 | Up a level |
Khan, Safi U; Yedlapati, Siva H; Lone, Ahmad N; Hao, Qiukui; Guyatt, Gordon; Delvaux, Nicolas; Bekkering, Geertruida E Trudy; Vandvik, Per Olav; Riaz, Irbaz Bin; Li, Sheyu; Aertgeerts, Bert; Rodondi, Nicolas (2022). PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis. BMJ, 377, e069116. BMJ Publishing Group 10.1136/bmj-2021-069116
Hao, Qiukui; Aertgeerts, Bert; Guyatt, Gordon; Bekkering, Geertruida E; Vandvik, Per Olav; Khan, Safi U; Rodondi, Nicolas; Jackson, Rod; Reny, Jean-Luc; Al Ansary, Lubna; Van Driel, Mieke; Assendelft, Willem J J; Agoritsas, Thomas; Spencer, Frederick; Siemieniuk, Reed A C; Lytvyn, Lyubov; Heen, Anja Fog; Zhao, Qian; Riaz, Irbaz Bin; Ramaekers, Dirk; ... (2022). PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations. BMJ, 377, e069066. BMJ Publishing Group 10.1136/bmj-2021-069066
